Pharmaceutical excipients are more than inert fillers; they actively shape how an oral drug dissolves, is absorbed, and remains stable. Evidence and standard texts emphasize that excipient selection controls the physical and chemical environment of the active pharmaceutical ingredient, with direct consequences for bioavailability and shelf life. Michael E. Aulton, King's College London, describes these roles in foundational pharmaceutics literature, and the Handbook of Pharmaceutical Excipients edited by Rowe, Sheskey, and Owen, Pharmaceutical Press, catalogs functional effects and compatibilities.
Effects on oral absorption
Excipients influence absorption primarily by modifying dissolution, disintegration, and permeability. Disintegrants and hydrophilic fillers promote breakup of tablets to expose drug surface area and speed dissolution; surfactants and wetting agents improve solubility for poorly water-soluble drugs. pH modifiers and buffers alter the microenvironmental pH inside a dosage form, which can increase drug solubility in the gastrointestinal tract. Some excipients act as permeability enhancers or enzyme inhibitors to increase mucosal uptake, while others like certain lipids form matrices that slow release. Ali Nokhodchi, University of Nottingham, has published extensively on formulation strategies for enhancing oral bioavailability of low-solubility drugs. Regulatory resources such as the U.S. Food and Drug Administration inactive ingredient listings guide permissible excipient choices for different routes and strengths.
Effects on chemical and physical stability
Stability outcomes depend on excipient chemistry and excipient–drug interactions. Hygroscopic excipients can draw moisture, accelerating hydrolysis of susceptible drugs; reducing sugars like lactose can participate in the Maillard reaction with primary amines, causing discoloration and potency loss. Antioxidants, chelating agents, and pH buffers are chosen to reduce oxidative or metal-catalyzed degradation. Lubricants and coatings influence moisture barrier properties and mechanical robustness during manufacturing and transport. The United States Pharmacopeia and the European Medicines Agency provide standards and guidance that manufacturers use to assess excipient suitability and stability testing protocols.
Regional climates, manufacturing practices, and supply-chain variability introduce nuance—a formulation stable in a dry continental climate may require different excipients or protective packaging for a humid tropical market. Poor excipient choice can reduce efficacy, alter dosing requirements, or necessitate additional regulatory data, so formulation scientists balance functional performance with safety, regulatory limits, and environmental or cultural sourcing considerations.